Metformin as a multi-target modulator of atherosclerosis: integrated regulation of Nrf2/KLF2, mitochondrial homeostasis, inflammation, ferroptosis, and innate immunity

Journal of Pharmacy and Pharmacology · Published 2026-05-11 · DOI 10.1093/jpp/rgag056

Authors (7)

Mansour Alanazi, Hayder M Al-kuraishy, Aya M Mustafa, Mubarak Alruwaili, Athanasios Alexiou, Marios Papadakis, Gaber El-Saber Batiha

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Alanazi, M., Al-kuraishy, H., Mustafa, A., et al. (2026). Metformin as a multi-target modulator of atherosclerosis: integrated regulation of Nrf2/KLF2, mitochondrial homeostasis, inflammation, ferroptosis, and innate immunity. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgag056

Related articles